| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
Authors’ Reply to Mona Kargar and Colleagues’ Comment on “Adverse Drug Reaction-Related Hospitalizations in Elderly Australians: A Prospective Cross-Sectional Study in Two Tasmanian Hospitals”
|
Parameswaran Nair, Nibu
|
|
2017
|
41 |
3 |
p. 323-324
|
article
|
| 2 |
Can SGLT2 Inhibitors Cause Acute Renal Failure? Plausible Role for Altered Glomerular Hemodynamics and Medullary Hypoxia
|
Szalat, Auryan
|
|
2017
|
41 |
3 |
p. 239-252
|
article
|
| 3 |
Comment on: “Adverse Drug Reaction-Related Hospitalizations in Elderly Australians: A Prospective Cross-Sectional Study in Two Tasmanian Hospitals”
|
Kargar, Mona
|
|
2017
|
41 |
3 |
p. 321-322
|
article
|
| 4 |
Evaluation of ‘Definite’ Anaphylaxis Drug Allergy Alert Overrides in Inpatient and Outpatient Settings
|
Wong, Adrian
|
|
2017
|
41 |
3 |
p. 297-302
|
article
|
| 5 |
Neuropsychiatric Events Associated with Leukotriene-Modifying Agents: A Systematic Review
|
Law, Sharon W. Y.
|
|
2017
|
41 |
3 |
p. 253-265
|
article
|
| 6 |
Reported Adverse Events with Painkillers: Data Mining of the US Food and Drug Administration Adverse Events Reporting System
|
Min, Jae
|
|
2017
|
41 |
3 |
p. 313-320
|
article
|
| 7 |
Risk of Psoriasis Following Terbinafine or Itraconazole Treatment for Onychomycosis: A Population-Based Case-Control Comparative Study
|
Chiu, Hsien-Yi
|
|
2017
|
41 |
3 |
p. 285-295
|
article
|
| 8 |
Severe Physical Complications among Survivors of Stevens–Johnson Syndrome and Toxic Epidermal Necrolysis
|
Olteanu, Cristina
|
|
2017
|
41 |
3 |
p. 277-284
|
article
|
| 9 |
Using Human ‘Experiments of Nature’ to Predict Drug Safety Issues: An Example with PCSK9 Inhibitors
|
Jerome, Rebecca N.
|
|
2017
|
41 |
3 |
p. 303-311
|
article
|
| 10 |
Utilisation and Safety of Deferasirox: Results from an Observational Cohort Study in England
|
Osborne, Vicki
|
|
2017
|
41 |
3 |
p. 267-275
|
article
|
Journal description